Acura Pharmaceuticals reported 1.11M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.69M 0.66M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Rigel Pharmaceuticals RIGL:US $ 54.96M 4.27M
Shionogi 4507:JP Y 129836M 5440M
Teva Pharmaceutical TEVA:IT 11B 617M
Xeris Pharmaceuticals Inc XERS:US $ 64.54M 1.95M